Awarded a partially refundable grant for research project: Bluespe
Tue, 31/07/2018 - 00:00
1 minAwarded a partially refundable grant for research project: Bluespe
Related
ROVI takes first place in the Sustainalytics world ESG risk ranking for the second year running
Laboratorios Farmacéuticos...
3 min
04/08/2023
ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®
The United States Food and Drug Administration (...
1 min
28/07/2023
ROVI ACHIEVED STABLE TOTAL REVENUE OF 381.0 MILLION EUROS IN THE FIRST POST-PANDEMIC HALF YEAR
Operating revenue remained stable,...
4 min
26/07/2023
Awarded a partially refundable grant for research project: Bluespe